Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

Author(s):
Heijde, D. van der; Dougados, M.; Landewe, R.; Sieper, J.; Maksymowych, W.P.; Rudwaleit, M.; Bosch, F. van den; Braun, J.; Mease, P.J.; Kivitz, A.J.; Walsh, J.; Davies, O.; Bauer, L.; Hoepken, B.; Peterson, L.; Deodhar, A.
Published
2017
Publication type
Article / Letter to editor
axial spondyloarthritisankylosing spondylitisnon-radiographic axial spondyloarthritiscertolizumab pegol
Date issued
2017-09-30
Language
English
Is part of
Rheumatology (2017), Vol. 56, no. 9, p. 1498-1509
hdl
1887/116198
doi
10.1093/rheumatology/kex174